/EKNL

EKNL Stock - EKO International Corp.

Q: What is the analyst price target for EKNL?

Analyst price target information is not currently available for EKNL.

Q: What is EKNL's market cap?

Market capitalization information is not currently available for EKNL.

Industrials|Conglomerates|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for EKNL

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY1995

FY1996

FY1999

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.46

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY1999	FY1996	FY1995
Revenue	N/A	$100,000	$100,000
Gross Profit	$-692,956	$-600,000	N/A
Gross Margin	N/A	-600.0%	0.0%
Operating Income	$-725,284	$-2,800,000	$-2,700,000
Net Income	$-801,504	$-3,000,000	$-2,600,000
Net Margin	N/A	-3000.0%	-2600.0%
EPS	$0.00	$0.00	$0.00

Company Overview

EKO International Corp., through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada. The company, through its joint venture interest in NeuroVasc Clinical Inc., also sets up and/or manage clinics to treat patients using FREMSTM equipment. EKO International Corp. is based in Burlington, Canada.

Frequently Asked Questions about EKNL

What is EKNL's current stock price?

EKO International Corp. (EKNL) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for EKNL?

No analyst price targets are currently available for this stock.

What sector is EKO International Corp. in?

EKO International Corp. operates in the Industrials sector, specifically within the Conglomerates industry. The company is traded on the OTC exchange.

What is EKNL's market cap?

EKO International Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does EKNL pay dividends?

No, EKO International Corp. does not currently pay a dividend to shareholders.